MicroRNAs expression profiles in cardiovascular diseases

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Bronze Da Rocha, Elsa ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; BIOLOGICAL MARKER; MESSENGER RNA; TRANSCRIPTOME;

BIOGENESIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE MARKER; HEART FAILURE; HEART INFARCTION; HUMAN; MATURATION; NOMENCLATURE; NONHUMAN; REVIEW; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84903647962     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/985408     Document Type: Review

References (156)

1. Rodríguez-Rodero S., Fernández-Morera J. L., Fernandez A. F., Menéndez-Torre E., Fraga M. F., Epigenetic regulation of aging. Discovery Medicine 2010 10 52 225 233
2. D'Aquila P., Rose G., Bellizzi D., Passarino G., Epigenetics and aging. Maturitas 2013 74 2 130 136 2-s2.0-84872180216 10.1016/j.maturitas.2012.11.005
3. Dimmeler S., Nicotera P., MicroRNAs in age-related diseases. EMBO Molecular Medicine 2013 5 2 180 190 2-s2.0-84873298811 10.1002/emmm.201201986
4. Kenyon C. J., The genetics of ageing. Nature 2010 464 7288 504 512 2-s2.0-77950200010 10.1038/nature08980
5. North B. J., Sinclair D. A., The intersection between aging and cardiovascular disease. Circulation Research 2012 110 8 1097 1108 2-s2.0-84859882975 10.1161/CIRCRESAHA.111.246876
6. López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G., The hallmarks of aging. Cell 2013 153 6 1194 1217 2-s2.0-84878864199 10.1016/j.cell.2013.05.039
7. Gems D., Partridge L., Genetics of longevity in model organisms: debates and paradigm shifts. Annual Review of Physiology 2013 75 621 644 2-s2.0-84873633910 10.1146/annurev-physiol-030212-183712
8. Gems D., de la Guardia Y., Alternative perspectives on aging in caenorhabditis elegans: reactive oxygen species or hyperfunction? Antioxidants and Redox Signaling 2013 19 3 321 329 2-s2.0-84879513284 10.1089/ars.2012.4840
9. Inukai S., Slack F., MicroRNAs and the genetic network in aging. Journal of Molecular Biology 2013 425 19 3601 3608 2-s2.0-84873501794 10.1016/j.jmb.2013.01.023
10. Latronico M. V., Catalucci D., Condorelli G., Emerging role of microRNAs in cardiovascular biology. Circulation Research 2007 101 12 1225 1236 2-s2.0-37349042225 10.1161/CIRCRESAHA.107.163147 (Pubitemid 350294639)
11. Ikeda S., Kong S. W., Lu J., Bisping E., Zhang H., Allen P. D., Golub T. R., Pieske B., Pu W. T., Altered microRNA expression in human heart disease. Physiological Genomics 2007 31 3 367 373 2-s2.0-36248948593 10.1152/ physiolgenomics.00144.2007 (Pubitemid 350127777)
12. Garzon R., Croce C. M., MicroRNAs in normal and malignant hematopoiesis. Current Opinion in Hematology 2008 15 4 352 358 2-s2.0-47149109822 10.1097/MOH.0b013e328303e15d
13. Latronico M. V., Condorelli G., MicroRNAs and cardiac pathology. Nature Reviews Cardiology 2009 6 6 419 429 2-s2.0-69249235447
14. Kai Z. S., Pasquinelli A. E., MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nature Structural and Molecular Biology 2010 17 1 5 10 2-s2.0-77449131843
15. Huang X. A., Lin H., s The miRNA regulation of stem cells. Wiley Interdisciplinary Reviews: Membrane Transport and Signaling 2012 1 1 83 95
16. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
17. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
18. Thum T., Catalucci D., Bauersachs J., MicroRNAs: novel regulators in cardiac development and disease. Cardiovascular Research 2008 79 4 562 570 2-s2.0-52449116560 10.1093/cvr/cvn137
19. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M. J., Tuschl T., Margalit H., Clustering and conservation patterns of human microRNAs. Nucleic Acids Research 2005 33 8 2697 2706 2-s2.0-18744367544 10.1093/nar/gki567 (Pubitemid 41511287)
20. Lee Y., Kim M., Han J., Yeom K., Lee S., Baek S. H., Kim V. N., MicroRNA genes are transcribed by RNA polymerase II. The EMBO Journal 2004 23 20 4051 4060 2-s2.0-8144225486 10.1038/sj.emboj.7600385 (Pubitemid 39472426)
21. Fazi F., Nervi C., MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovascular Research 2008 79 4 553 561 2-s2.0-52449093137 10.1093/cvr/cvn151
22. Borchert G. M., Lanier W., Davidson B. L., RNA polymerase III transcribes human microRNAs. Nature Structural and Molecular Biology 2006 13 12 1097 1101 2-s2.0-33845370280 10.1038/nsmb1167 (Pubitemid 44885920)
23. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V. N., The nuclear RNase III Drosha initiates microRNA processing. Nature 2003 425 6956 415 419 2-s2.0-0141843656 10.1038/nature01957 (Pubitemid 37187272)
24. Winter J., Jung S., Keller S., Gregory R. I., Diederichs S., Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology 2009 11 3 228 234 2-s2.0-61849137222 10.1038/ncb0309-228
25. Matranga C., Tomari Y., Shin C., Bartel D. P., Zamore P. D., Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 2005 123 4 607 620 2-s2.0-27744590896 10.1016/j.cell.2005.08.044 (Pubitemid 41608464)
26. Rand T. A., Petersen S., Du F., Wang X., Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 2005 123 4 621 629 2-s2.0-27744506761 10.1016/j.cell.2005.10.020 (Pubitemid 41608465)
27. Krek A., Grün D., Poy M. N., Wolf R., Rosenberg L., Epstein E. J., MacMenamin P., Da Piedade I., Gunsalus K. C., Stoffel M., Rajewsky N., Combinatorial microRNA target predictions. Nature Genetics 2005 37 5 495 500 2-s2.0-20944450160 10.1038/ng1536 (Pubitemid 40617277)
28. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
29. Thomas M., Lieberman J., Lal A., Desperately seeking microRNA targets. Nature Structural and Molecular Biology 2010 17 10 1169 1174 2-s2.0-77957766910 10.1038/nsmb.1921
30. Lytle J. R., Yario T. A., Steitz J. A., Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proceedings of the National Academy of Sciences of the United States of America 2007 104 23 9667 9672 2-s2.0-34547441263 10.1073/pnas.0703820104 (Pubitemid 47175324)
31. Qin W., Shi Y., Zhao B., Yao C., Jin L., Ma J., Jin Y., MiR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS ONE 2010 5 2 2-s2.0-77949731645 10.1371/journal.pone.0009429 e9429
32. Eulalio A., Huntzinger E., Izaurralde E., Getting to the root of miRNA-mediated gene silencing. Cell 2008 132 1 9 14 2-s2.0-37648998629 10.1016/j.cell.2007.12.024
33. Bhatt K., Mi Q. S., Dong Z., MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. American Journal of Physiology-Renal Physiology 2011 300 3 F602 F610 2-s2.0-79954468469 10.1152/ajprenal.00727.2010
34. Berezikov E., Chung W., Willis J., Cuppen E., Lai E. C., Mammalian mirtron genes. Molecular Cell 2007 28 2 328 336 2-s2.0-35348933779 10.1016/j.molcel.2007.09.028 (Pubitemid 47600007)
35. Miyoshi K., Miyoshi T., Siomi H., Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Molecular Genetics and Genomics 2010 284 2 95 103 2-s2.0-77955290050 10.1007/s00438-010-0556-1
36. Sibley C. R., Seow Y., Saayman S., Dijkstra K. K., El Andaloussi S., Weinberg M. S., Wood M. J. A., The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Research 2012 40 1 438 448 2-s2.0-84855275505 10.1093/nar/gkr722
37. Lin S.-L., Miller J. D., Ying S.-Y., Intronic microRNA (miRNA). Journal of Biomedicine and Biotechnology 2006 2006 13 2-s2.0-33746782086 10.1155/JBB/2006/26818 26818 (Pubitemid 44182137)
38. Lin S. L., Ying S. Y., Gene silencing in vitro and in vivo using intronic microRNAs. Methods in Molecular Biology 2013 936 209 229 2-s2.0-84878894708
39. Ambros V., Bartel B., Bartel D. P., Burge C. B., Carrington J. C., Chen X., Dreyfuss G., Eddy S. R., Griffiths-Jones S., Marshall M., Matzke M., Ruvkun G., Tuschl T., A uniform system for microRNA annotation. RNA 2003 9 3 277 279 2-s2.0-0037370020 10.1261/rna.2183803 (Pubitemid 36246165)
40. Griffiths-Jones S., The microRNA registry. Nucleic Acids Research 2004 32 D109 D111 2-s2.0-0347755643 (Pubitemid 38081615)
41. Griffiths-Jones S., Grocock R. J., van Dongen S., Bateman A., Enright A. J., MiRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research 2006 34 D140 D144 2-s2.0-33644750115
42. Saito Y., Liang G., Egger G., Friedman J. M., Chuang J. C., Coetzee G. A., Jones P. A., Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006 9 6 435 443 2-s2.0-33744805399 10.1016/j.ccr.2006.04.020 (Pubitemid 43832188)
43. Diederichs S., Haber D. A., Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007 131 6 1097 1108 2-s2.0-36849048778 10.1016/j.cell.2007.10.032 (Pubitemid 350235019)
44. Scadden A. D., The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nature Structural and Molecular Biology 2005 12 6 489 496 2-s2.0-22144444302 10.1038/nsmb936 (Pubitemid 43085878)
45. Yang W., Chendrimada T. P., Wang Q., Higuchi M., Seeburg P. H., Shiekhattar R., Nishikura K., Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nature Structural and Molecular Biology 2006 13 1 13 21 2-s2.0-30044443191 10.1038/nsmb1041 (Pubitemid 43049397)
46. Kawahara Y., Megraw M., Kreider E., Iizasa H., Valente L., Hatzigeorgiou A. G., Nishikura K., Frequency and fate of microRNA editing in human brain. Nucleic Acids Research 2008 36 16 5270 5280 2-s2.0-52649128795 10.1093/nar/gkn479
47. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
48. Hamilton A. J., MicroRNA in erythrocytes. Biochemical Society Transactions 2010 38, part 1 229 231 2-s2.0-76449086977 10.1042/BST0380229
49. Creemers E. E., Tijsen A. J., Pinto Y. M., Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation Research 2012 110 3 483 495 2-s2.0-84856695673 10.1161/CIRCRESAHA. 111.247452
50. Li C., Pei F., Zhu X., Duan D. D., Zeng C., Circulating microRNAs as novel and sensitive biomarkers of acute myocardial infarction. Clinical Biochemistry 2012 45 10-11 727 732 2-s2.0-84862583782 10.1016/j.clinbiochem. 2012.04.013
51. Wang K., Zhang S., Weber J., Baxter D., Galas D. J., Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research 2010 38 20 7248 7259 2-s2.0-78149409316 10.1093/nar/gkq601
52. Kinet V., Halkein J., Dirkx E., Windt L. I., Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication. Frontiers in Genetics 2013 4, article 214 10.3389/fgene.2013. 00214
53. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Köppel T., Jahantigh M. N., Lutgens E., Wang S., Olson E. N., Schober A., Weber C., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling 2009 2 100 ra81 2-s2.0-77449127999 10.1126/scisignal.2000610
54. Dimmeler S., Zeiher A. M., Circulating microRNAs: novel biomarkers for cardiovascular diseases? European Heart Journal 2010 31 22 2705 2707 2-s2.0-78649375442 10.1093/eurheartj/ehq221
55. Etheridge A., Lee I., Hood L., Galas D., Wang K., Extracellular microRNA: a new source of biomarkers. Mutation Research 2011 717 1-2 85 90 2-s2.0-82755187564 10.1016/j.mrfmmm.2011.03.004
56. Tijsen A. J., Pinto Y. M., Creemers E. E., Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. American Journal of Physiology-Heart and Circulatory Physiology 2012 303 9 H1085 H1095 2-s2.0-84868346560 10.1152/ajpheart.00191.2012
57. Sayed D., Abdellatif M., Micrornas in development and disease. Physiological Reviews 2011 91 3 827 887 2-s2.0-79960104144 10.1152/physrev. 00006.2010
58. Caroli A., Cardillo M. T., Galea R., Biasucci L. M., Potential therapeutic role of microRNAs in ischemic heart disease. Journal of Cardiology 2013 61 5 315 320 2-s2.0-84877616567 10.1016/j.jjcc.2013.01.012
59. Janssen H. L., Reesink H. W., Lawitz E. J., Treatment of HCV infection by targeting microRNAs. The New England Journal of Medicine 2013 368 18 1685 1694 10.1056/NEJMoa1209026
60. Dangwal S., Thum T., MicroRNA therapeutics in cardiovascular disease models. Annual Review of Pharmacology and Toxicology 2014 54 185 203 10.1146/annurev-pharmtox-011613-135957
61. Galasso M., Sana M. E., Volinia S., Non-coding RNAs: a key to future personalized molecular therapy? Genome Medicine 2010 2 2, article 12 2-s2.0-77955013582 10.1186/gm133
62. Fasanaro P., Greco S., Ivan M., Capogrossi M. C., Martelli F., MicroRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacology and Therapeutics 2010 125 1 92 104 2-s2.0-72049101201 10.1016/j.pharmthera.2009.10. 003
63. Oliveira-Carvalho V., da Silva M. M., Guimarães G. V., Bacal F., Bocchi E. A., MicroRNAs: new players in heart failure. Molecular Biology Reports 2013 40 3 2663 2670 2-s2.0-84878421000 10.1007/s11033-012-2352-y
64. van Rooij E., Purcell A. L., Levin A. A., Developing microRNA therapeutics. Circulation Research 2012 110 3 496 507 2-s2.0-84856751210 10.1161/CIRCRESAHA.111.247916
65. Weiler J., Hunziker J., Hall J., Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Therapy 2006 13 6 496 502 2-s2.0-33645135862 10.1038/sj.gt.3302654
66. Xu J., Zhao J., Evan G., Xiao C., Cheng Y., Xiao J., Circulating microRNAs: novel biomarkers for cardiovascular diseases. Journal of Molecular Medicine 2012 90 8 865 875 2-s2.0-84865128457 10.1007/s00109-011-0840-5
67. Lakatta E. G., Levy D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 2003 107 1 139 146 2-s2.0-0037422592 10.1161/01.CIR.0000048892.83521.58 (Pubitemid 36070946)
68. Lakatta E. G., Levy D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003 107 2 346 354 2-s2.0-0037458070 10.1161/01.CIR.0000048893.62841.F7 (Pubitemid 36135235)
69. Dimmeler S., Leri A., Aging and disease as modifiers of efficacy of cell therapy. Circulation Research 2008 102 11 1319 1330 2-s2.0-44949181955 10.1161/CIRCRESAHA.108.175943
70. Strait J. B., Lakatta E. G., Aging-associated cardiovascular changes and their relationship to heart failure. Heart Failure Clinics 2012 8 1 143 164 2-s2.0-82955249843 10.1016/j.hfc.2011.08.011
71. Salic K., de Windt L. J., MicroRNAs as biomarkers for myocardial infarction. Current Atherosclerosis Reports 2012 14 3 193 200 2-s2.0-84861226953 10.1007/s11883-012-0238-z
72. Fichtlscherer S., Zeiher A. M., Dimmeler S., Circulating microRNAs: biomarkers or mediators of cardiovascular diseases. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 11 2383 2390 2-s2.0-80054942985 10.1161/ATVBAHA.111.226696
73. Hoekstra M., van der Lans C. A. C., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., van Berkel T. J. C., Biessen E. A. L., The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochemical and Biophysical Research Communications 2010 394 3 792 797 2-s2.0-77950518455 10.1016/j.bbrc.2010.03.075
74. Diehl P., Fricke A., Sander L., Stamm J., Bassler N., Htun N., Ziemann M., Helbing T., El-Osta A., Jowett J. B. M., Peter K., Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovascular Research 2012 93 4 633 644 2-s2.0-84857975438 10.1093/cvr/cvs007
75. D'Alessandra Y., Carena M. C., Spazzafumo L., Diagnostic potential of plasmatic microRNA signatures in stable and unstable angina. PLoS ONE 2013 8 11 10.1371/journal.pone.0080345 e80345
76. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P. G., Rubino M., Carena M. C., Spazzafumo L., De Simone M., Micheli B., Biglioli P., Achilli F., Martelli F., Maggiolini S., Marenzi G., Pompilio G., Capogrossi M. C., Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal 2010 31 22 2765 2773 2-s2.0-78549270354 10.1093/eurheartj/ehq167
77. Sondermeijer B. M., Bakker A., Halliani A., de Ronde M. W. J., Marquart A. A., Tijsen A. J., Mulders T. A., Kok M. G. M., Battjes S., Maiwald S., Sivapalaratnam S., Trip M. D., Moerland P. D., Meijers J. C. M., Creemers E. E., Pinto-Sietsma S., Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340340 and miRNA624 PLoS ONE 2011 6 10 2-s2.0-80054085814 10.1371/journal.pone.0025946 e25946
78. de Rosa S., Fichtlscherer S., Lehmann R., Assmus B., Dimmeler S., Zeiher A. M., Transcoronary concentration gradients of circulating microRNAs. Circulation 2011 124 18 1936 1944 2-s2.0-80255135653 10.1161/CIRCULATIONAHA.111. 037572
79. Matkovich S. J., Hu Y., Eschenbacher W. H., Dorn L. E., Dorn G. W. 2nd, Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circulation Research 2012 111 5 521 531 2-s2.0-84865527591 10.1161/CIRCRESAHA.112.265736
80. Fish J. E., Santoro M. M., Morton S. U., Yu S., Yeh R., Wythe J. D., Ivey K. N., Bruneau B. G., Stainier D. Y. R., Srivastava D., MiR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 2008 15 2 272 284 2-s2.0-48749130187 10.1016/j.devcel.2008.07.008
81. Xiong X. D., Cho M., Cai X. P., A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutation Research 2014 761 15 20 10.1016/j.mrfmmm.2014.01.001
82. Ramkaran P., Khan S., Phulukdaree A., Moodley D., Chuturgoon A. A., MiR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochemistry and Biophysics 2014 68 2 259 266 2-s2.0-84879038562 10.1007/s12013-013-9704-7
83. Fichtlscherer S., de Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C. W., Röxe T., Müller-Ardogan M., Bonauer A., Zeiher A. M., Dimmeler S., Circulating microRNAs in patients with coronary artery disease. Circulation Research 2010 107 5 677 684 2-s2.0-77957028990 10.1161/CIRCRESAHA.109.215566
84. Weber M., Baker M. B., Patel R. S., Quyyumi A. A., Bao G., Searles C. D., MicroRNA expression profile in CAD patients and the impact of ACEI/ARB. Cardiology Research and Practice 2011 2011 5 2-s2.0-80052678985 10.4061/2011/532915 532915
85. Zhang Q., Kandic I., Kutryk M. J., Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochemical and Biophysical Research Communications 2011 405 1 42 46 2-s2.0-79551474502 10.1016/j.bbrc.2010.12.119
86. Minami Y., Satoh M., Maesawa C., Takahashi Y., Tabuchi T., Itoh T., Nakamura M., Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. European Journal of Clinical Investigation 2009 39 5 359 367 2-s2.0-63849261167 10.1111/j.1365-2362.2009.02110.x
87. Li T., Cao H., Zhuang J., Wan J., Guan M., Yu B., Li X., Zhang W., Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clinica Chimica Acta 2011 412 1-2 66 70 2-s2.0-78650512343 10.1016/j.cca.2010.09.029
88. Takahashi Y., Satoh M., Minami Y., Tabuchi T., Itoh T., Nakamura M., Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clinical Science 2010 119 9 395 405 2-s2.0-77956378275 10.1042/CS20100003
89. Taurino C., Miller W. H., McBride M. W., McClure J. D., Khanin R., Moreno M. U., Dymott J. A., Delles C., Dominiczak A. F., Gene expression profiling in whole blood of patients with coronary artery disease. Clinical Science 2010 119 8 335 343 2-s2.0-77956363202 10.1042/CS20100043
90. Torres M., Moayedi S., Evaluation of the acutely dyspneic elderly patient. Clinics in Geriatric Medicine 2007 23 2 307 325 2-s2.0-34247371065 10.1016/j.cger.2007.01.007 (Pubitemid 46629006)
91. Cheng Y., Tan N., Yang J., Liu X., Cao X., He P., Dong X., Qin S., Zhang C., A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical Science 2010 119 2 87 95 2-s2.0-77954932535 10.1042/CS20090645
92. Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J., Li K., Yu B., Li Z., Wang R., Wang L., Li Q., Wang N., Shan H., Li Z., Yang B., Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications 2010 391 1 73 77 2-s2.0-72949112451 10.1016/j.bbrc.2009.11.005
93. Long G., Wang F., Duan Q., Chen F., Yang S., Gong W., Wang Y., Chen C., Wang D. W., Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. International Journal of Biological Sciences 2012 8 6 811 818 2-s2.0-84863763858 10.7150/ijbs.4439
94. Ikeda S., Kong S. W., Lu J., MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Molecular and Cellular Biology 2009 29 8 2193 2204 10.1128/MCB.01222-08
95. Vogel B., Keller A., Frese K. S., Kloos W., Kayvanpour E., Sedaghat-Hamedani F., Hassel S., Marquart S., Beier M., Giannitis E., Hardt S., Katus H. A., Meder B., Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction. Clinical Chemistry 2013 59 2 410 418 2-s2.0-84873189733 10.1373/clinchem.2011.181370
96. Li Y. Q., Zhang M. F., Wen H. Y., Hu C., Liu R., Wei H., Ai C., Wang G., Liao X., Li X., Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics 2013 68 1 75 80 2-s2.0-84874167323 10.6061/clinics/2013(01)OA12
97. Adachi T., Nakanishi M., Otsuka Y., Nishimura K., Hirokawa G., Goto Y., Nonogi H., Iwai N., Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical Chemistry 2010 56 7 1183 1185 2-s2.0-77954355260 10.1373/clinchem.2010.144121
98. Corsten M. F., Dennert R., Jochems S., Kuznetsova T., Devaux Y., Hofstra L., Wagner D. R., Staessen J. A., Heymans S., Schroen B., Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circulation: Cardiovascular Genetics 2010 3 6 499 506 2-s2.0-79952783637 10.1161/CIRCGENETICS.110.957415
99. Devaux Y., Vausort M., Goretti E., Nazarov P. V., Azuaje F., Gilson G., Corsten M. F., Schroen B., Lair M., Heymans S., Wagner D. R., Use of circulating microRNAs to diagnose acute myocardial infarction. Clinical Chemistry 2012 58 3 559 567 2-s2.0-84857806602 10.1373/clinchem.2011.173823
100. Boštjančič E., Zidar N., Štajer D., Glavač D., MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010 115 3 163 169 2-s2.0-72149133679 10.1159/000268088
101. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N., Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry 2009 55 11 1944 1949 2-s2.0-70449709345 10.1373/clinchem.2009.125310
102. Callis T. E., Pandya K., Seok H. Y., Tang R., Tatsuguchi M., Huang Z., Chen J., Deng Z., Gunn B., Shumate J., Willis M. S., Selzman C. H., Wang D., MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. Journal of Clinical Investigation 2009 119 9 2772 2786 2-s2.0-70349202176 10.1172/JCI36154
103. Wang G. K., Zhu J. Q., Zhang J. T., Li Q., Li Y., He J., Qin Y., Jing Q., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 2010 31 6 659 666 2-s2.0-77954161288 10.1093/eurheartj/ehq013
104. Gidlöf O., Andersson P., van der Pals J., Götberg M., Erlinge D., Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 2011 118 4 217 226 2-s2.0-79959419859 10.1159/000328869
105. Widera C., Gupta S. K., Lorenzen J. M., Bang C., Bauersachs J., Bethmann K., Kempf T., Wollert K. C., Thum T., Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of Molecular and Cellular Cardiology 2011 51 5 872 875 2-s2.0-80053230332 10.1016/j.yjmcc.2011. 07.011
106. Gidlöf O., Smith J. G., Miyazu K., Gilje P., Spencer A., Blomquist S., Erlinge D., Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovascular Disorders 2013 13, article 12 2-s2.0-84874361869 10.1186/1471-2261-13-12
107. Eitel I., Adams V., Dieterich P., Fuernau G., De Waha S., Desch S., Schuler G., Thiele H., Relation of circulating microRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. American Heart Journal 2012 164 5 706 714 2-s2.0-84868609009 10.1016/j.ahj.2012.08.004
108. Cheng Y., Zhang C., MicroRNA-21 in cardiovascular disease. Journal of Cardiovascular Translational Research 2010 3 3 251 255 2-s2.0-77955661579 10.1007/s12265-010-9169-7
109. Dong S., Cheng Y., Yang J., Li J., Liu X., Wang X., Wang D., Krall T. J., Delphin E. S., Zhang C., MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. The Journal of Biological Chemistry 2009 284 43 29514 29525 2-s2.0-70350353082 10.1074/jbc.M109.027896
110. Cheng Y., Zhu P., Yang J., Liu X., Dong S., Wang X., Chun B., Zhuang J., Zhang C., Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovascular Research 2010 87 3 431 439 2-s2.0-77954797933 10.1093/cvr/cvq082
111. Zile M. R., Mehurg S. M., Arroyo J. E., Stroud R. E., DeSantis S. M., Spinale F. G., Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circulation: Cardiovascular Genetics 2011 4 6 614 619 2-s2.0-84856112345 10.1161/CIRCGENETICS.111.959841
112. Kuwabara Y., Ono K., Horie T., Nishi H., Nagao K., Kinoshita M., Watanabe S., Baba O., Kojima Y., Shizuta S., Imai M., Tamura T., Kita T., Kimura T., Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation: Cardiovascular Genetics 2011 4 4 446 454 2-s2.0-80052760391 10.1161/CIRCGENETICS.110.958975
113. Bauters C., Kumarswamy R., Holzmann A., Bretthauer J., Anker S. D., Pinet F., Thum T., Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. International Journal of Cardiology 2013 168 3 1837 1840 2-s2.0-84872389272 10.1016/j.ijcard.2012.12.074
114. Devaux Y., Vausort M., McCann G. P., MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circulation: Cardiovascular Genetics 2013 6 3 290 298 10.1161/CIRCGENETICS.113.000077
115. Wang F., Long G., Zhao C., Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. Journal of Translational Medicine 2013 11, article 222 10. 1186/1479-5876-11-222
116. Nabiałek E., Wańha W., Kula D., Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiologica 2013 61 6 627 637
117. Olivieri F., Antonicelli R., Lorenzi M., D'Alessandra Y., Lazzarini R., Santini G., Spazzafumo L., Lisa R., La Sala L., Galeazzi R., Recchioni R., Testa R., Pompilio G., Capogrossi M. C., Procopio A. D., Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International Journal of Cardiology 2013 167 2 531 536 2-s2.0-84879119108 10.1016/j.ijcard.2012.01.075
118. Tijsen A. J., Creemers E. E., Moerland P. D., De Windt L. J., Van Der Wal A. C., Kok W. E., Pinto Y. M., MiR423-5p as a circulating biomarker for heart failure. Circulation Research 2010 106 6 1035 1039 2-s2.0-77950973372 10.1161/CIRCRESAHA.110.218297
119. Ward J. A., Esa N., Pidikiti R., Circulating cell and plasma microRNA profiles differ between Non-ST-segment and ST-segment-elevation myocardial infarction. Family Medicine and Medical Science Research 2013 2 2 108 112 10.4172/2327-4972.1000108
120. Wang R., Li N., Zhang Y., Ran Y., Pu J., Circulating micro RNAs are promising novel biomarkers of acute myocardial infarction. Internal Medicine 2011 50 17 1789 1795 2-s2.0-80052418905 10.2169/internalmedicine.50.5129
121. Devaux Y., Mueller M., Haaf P., Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. Journal of Internal Medicine 2013 10.1111/joim.12183
122. Matsumoto S., Sakata Y., Nakatani D., Suna S., Mizuno H., Shimizu M., Usami M., Sasaki T., Sato H., Kawahara Y., Hamasaki T., Nanto S., Hori M., Komuro I., A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochemical and Biophysical Research Communications 2012 427 2 280 284 2-s2.0-84867870687 10.1016/j.bbrc.2012.09.039
123. Meder B., Keller A., Vogel B., Haas J., Sedaghat-Hamedani F., Kayvanpour E., Just S., Borries A., Rudloff J., Leidinger P., Meese E., Katus H. A., Rottbauer W., MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Research in Cardiology 2011 106 1 13 23 2-s2.0-79151477621 10.1007/s00395-010-0123-2
124. Long G., Wang F., Duan Q., Yang S., Chen F., Gong W., Yang X., Wang Y., Chen C., Wang D. W., Navarro A., Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 2012 7 12 2-s2.0-84870900923 10.1371/journal.pone.0050926 e50926
125. Chen J., Huang Z. P., Seok H. Y., Ding J., Kataoka M., Zhang Z., Hu X., Wang G., Lin Z., Wang S., Pu W. T., Liao R., Wang D., Mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circulation Research 2013 112 12 1557 1566 2-s2.0-84880040358 10.1161/CIRCRESAHA.112.300658
126. Naga Prasad S. V., Duan Z. H., Gupta M. K., Surampudi V. S. K., Volinia S., Calin G. A., Liu C., Kotwal A., Moravec C. S., Starling R. C., Perez D. M., Sen S., Wu Q., Plow E. F., Croce C. M., Karnik S., Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. The Journal of Biological Chemistry 2009 284 40 27487 27499 2-s2.0-70350463883 10.1074/jbc.M109.036541
127. D'Andrea A., Salerno G., Scarafile R., Riegler L., Gravino R., Castaldo F., Cocchia R., Limongelli G., Romano M., CalabrÒ P., Nigro G., Cuomo S., Bossone E., Caso P., CalabrÒ R., Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. Pacing and Clinical Electrophysiology 2009 32 8 1017 1029 2-s2.0-68349146024 10.1111/j.1540-8159.2009.02434.x
128. Kwon D. H., Halley C. M., Carrigan T. P., Zysek V., Popovic Z. B., Setser R., Schoenhagen P., Starling R. C., Flamm S. D., Desai M. Y., Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function. A delayed hyperenhancement cardiac magnetic resonance study. Journal of the American College of Cardiology Cardiovascular Imaging 2009 2 1 34 44 2-s2.0-58149342631 10.1016/j.jcmg.2008.09. 010
129. Olszowska M., Pathogenesis and pathophysiology of aortic valve stenosis in adults. Polish Archives of Internal Medicine 2011 121 11 409 413 2-s2.0-83055171417
130. Thum T., Galuppo P., Wolf C., MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007 116 3 258 267 (Pubitemid 47196561)
131. van Rooij E., Sutherland L. B., Liu N., Williams A. H., McAnally J., Gerard R. D., Richardson J. A., Olson E. N., A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2006 103 48 18255 18260 2-s2.0-33845317603 10.1073/pnas.0608791103 (Pubitemid 44871645)
132. Sucharov C., Bristow M. R., Port J. D., MiRNA expression in the failing human heart: functional correlates. Journal of Molecular and Cellular Cardiology 2008 45 2 185 192 2-s2.0-48849095818 10.1016/j.yjmcc.2008.04.014
133. Li D. F., Tian J., Guo X., Huang L. M., Xu Y., Wang C.-C., Wang J.-F., Ren A.-J., Yuan W.-J., Lin L., Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes. Physiological Research 2012 61 6 555 565 2-s2.0-84873839001
134. 2+ overload and cell death. Journal of Clinical Investigation 2012 122 4 1222 1232 2-s2.0-84859720170 10.1172/JCI59327
135. Matkovich S. J., van Booven D. J., Youker K. A., Torre-Amione G., Diwan A., Eschenbacher W. H., Dorn L. E., Watson M. A., Margulies K. B., Dorn G. W. II, Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009 119 9 1263 1271 2-s2.0-63649096271 10.1161/CIRCULATIONAHA.108. 813576
136. Fang J., Song X. W., Tian J., Chen H., Li D., Wang J., Ren A., Yuan W., Lin L., Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012 17 4 410 423 2-s2.0-84862504329 10.1007/s10495-011-0683-0
137. Ellis K. L., Cameron V. A., Troughton R. W., Frampton C. M., Ellmers L. J., Richards A. M., Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. European Journal of Heart Failure 2013 15 10 1138 1147
138. Goren Y., Kushnir M., Zafrir B., Tabak S., Lewis B. S., Amir O., Serum levels of microRNAs in patients with heart failure. European Journal of Heart Failure 2012 14 2 147 154 2-s2.0-84856208637 10.1093/eurjhf/hfr155
139. Fan K. L., Zhang H. F., Shen J., Zhang Q., Li X. L., Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart Journal 2013 65 1 12 16 2-s2.0-84874542644 10.1016/j.ihj.2012.12.022
140. Tutarel O., Dangwal S., Bretthauer J., Westhoff-Bleck M., Roentgen P., Anker S. D., Bauersachs J., Thum T., Circulating miR-423-5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. International Journal of Cardiology 2013 167 1 63 66 2-s2.0-84878558975 10.1016/j.ijcard.2011.11.082
141. Fukushima Y., Nakanishi M., Nonogi H., Goto Y., Iwai N., Assessment of plasma miRNAs in congestive heart failure. Circulation Journal 2011 75 2 336 340 2-s2.0-79251590758 10.1253/circj.CJ-10-0457
142. Jakob P., Doerries C., Briand S., Mocharla P., Kränkel N., Besler C., Mueller M., Manes C., Templin C., Baltes C., Rudin M., Adams H., Wolfrum M., Noll G., Ruschitzka F., Lüscher T. F., Landmesser U., Loss of angiomir-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 2012 126 25 2962 2975 2-s2.0-84871322435 10.1161/CIRCULATIONAHA.112.093906
143. Wang S., Aurora A. B., Johnson B. A., Qi X., McAnally J., Hill J. A., Richardson J. A., Bassel-Duby R., Olson E. N., The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell 2008 15 2 261 271 2-s2.0-48549106378 10.1016/j.devcel.2008.07.002
144. Voellenkle C., van Rooij J., Cappuzzello C., Greco S., Arcelli D., Di Vito L., Melillo G., Rigolini R., Costa E., Crea F., Capogrossi M. C., Napolitano M., Martelli F., MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiological Genomics 2010 42 3 420 426 2-s2.0-77955732822 10.1152/physiolgenomics.00211.2009
145. Qiang L., Hong L., Ningfu W., Huaihong C., Jing W., Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients. International Journal of Cardiology 2013 168 3 2082 2088 2-s2.0-84874034860 10.1016/j.ijcard.2013.01.160
146. Endo K., Naito Y., Ji X., Nakanishi M., Noguchi T., Goto Y., Nonogi H., Ma X., Weng H., Hirokawa G., Asada T., Kakinoki S., Yamaoka T., Fukushima Y., Iwai N., MicroRNA 210 as a biomarker for congestive heart failure. Biological and Pharmaceutical Bulletin 2013 36 1 48 54 2-s2.0-84872723386 10.1248/bpb.b12-00578
147. Zhao D. S., Chen Y., Jiang H., Lu J., Zhang G., Geng J., Zhang Q., Shen J., Zhou X., Zhu W., Shan Q., Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovascular Pathology 2013 22 6 444 450 2-s2.0-84876918682 10.1016/j.carpath.2013.04.001
148. Jeong M. H., Lee J. S., Kim D. H., Park W. J., Yang D. K., Identification of novel microRNAs negatively regulating cardiac hypertrophy. Biochemical and Biophysical Research Communications 2012 428 1 191 196 2-s2.0-84868347665 10.1016/j.bbrc.2012.10.040
149. Gurha P., Wang T., Larimore A. H., MicroRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS ONE 2013 8 9 e75882 10.1371/journal.pone.0075882
150. Huang Z. P., Chen J., Seok H. Y., Zhang Z., Kataoka M., Hu X., Wang D., MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circulation Research 2013 112 9 1234 1243 2-s2.0-84877583076 10.1161/CIRCRESAHA.112.300682
151. Carè A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M., Segnalini P., Gu Y., Dalton N. D., Elia L., Latronico M. V. G., Høydal M., Autore C., Russo M. A., Dorn G. W. II, Ellingsen Ø., Ruiz-Lozano P., Peterson K. L., Croce C. M., Peschle C., Condorelli G., MicroRNA-133 controls cardiac hypertrophy. Nature Medicine 2007 13 5 613 618 2-s2.0-34249279050 10.1038/nm1582 (Pubitemid 46828487)
152. Townley-Tilson W. H., Callis T. E., Wang D., MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. International Journal of Biochemistry and Cell Biology 2010 42 8 1252 1255 2-s2.0-77954385461 10.1016/j.biocel.2009.03.002
153. García R., Villar A. V., Cobo M., Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. Journal of the American Heart Association 2013 2 4 e000211 10.1161/JAHA.113.000211
154. Villar A. V., García R., Merino D., Llano M., Cobo M., Montalvo C., Martín-Durán R., Hurlé M. A., Nistal J. F., Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. International Journal of Cardiology 2013 167 6 2875 2881 2-s2.0-84864755145 10.1016/j.ijcard.2012.07.021
155. Beaumont J., López B., Hermida N., MicroRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF- β 1 up-regulation. Clinical Science 2014 126 7 497 506 10.1042/CS20130538
156. Ren J., Zhang J., Xu N., Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS ONE 2013 8 12 10.1371/journal.pone.0080738 e80738